Key Takeaways
- Biogena raised $25.0M.
- Sector: Healthcare, Healthtech & Medtech, Consumer.
- Geography: Austria, Germany, Italy.
Analysis
- Biogena, a Salzburg-based micronutrient manufacturer, is preparing for an IPO on the Vienna Stock Exchange.
- The company aims for a valuation of €470 million and is currently conducting a pre-listing capital increase of up to €25 million.
- Funds raised will be used for expanding production facilities, enhancing the webshop, and developing new store concepts.
- Biogena plans to enter the pharmacy channel in Austria, Germany, and Italy and is focusing on expansion in Germany due to lower brand awareness.
- The company projects significant revenue growth, aiming for €150 million this year and €500 million in the medium term.